Cheddar News
146

Pfizer BioNTech Children's COVID-19 Vaccine Trials Show Promising Antibody Boost

Pfizer and BioNTech announced promising results from its COVID-19 vaccine clinical trials in children, showing it was safe and that kids ages 5 to 11 saw a boost in antibodies after receiving the jab. Dr. Amesh Adalja, an infectious disease specialist, joined Cheddar to provide some more details about the highly anticipated announcement.

Science

Latest News

Business & Tech

Culture